A Study of Experimental Combination of CPX-351 and Gemtuzumab Ozogamicin For Relapsed Acute Myeloid Leukemia
Acute Myelogenous Leukemia AML, Leukemia Leukemia Leukemia, Myeloid Leukemia, Myeloid, Acute Cytarabine Daunorubicin Gemtuzumab Calicheamicins Gemtuzumab Ozogamicin Liposome-encapsulated Daunorubicin-Cytarabine
Lead Scientist at UC Davis
- Brian A. Jonas
Associate Professor, Hematology and Oncology. Authored (or co-authored) 58 research publications.